Modeling of novel diagnostic strategies for active tuberculosis - A systematic review: Current practices and recommendations

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Zwerling, Alice ^a   White, Richard G ^b   Vassall, Anna ^b   Cohen, Ted ^c   Dowdy, David W ^a   Houben, Rein M G J ^b  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLORIMETRY; COST EFFECTIVENESS ANALYSIS; DELAYED DIAGNOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DRUG SENSITIVITY; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; HUMAN; INCIDENCE; LIGHT EMITTING DIODE; MASS RADIOGRAPHY; MATHEMATICAL MODEL; MICROSCOPY; MORTALITY; MTT ASSAY; NUCLEIC ACID AMPLIFICATION; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEROLOGY; SPUTUM EXAMINATION; SYSTEMATIC REVIEW; THORAX RADIOGRAPHY; TUBERCULIN TEST; TUBERCULOSIS; CLINICAL PRACTICE; COST BENEFIT ANALYSIS; DIAGNOSTIC PROCEDURE; ECONOMICS; HEALTH CARE PLANNING; META ANALYSIS; THEORETICAL MODEL; TUBERCULOSIS, PULMONARY; UNCERTAINTY;

COST-BENEFIT ANALYSIS; DIAGNOSTIC TECHNIQUES AND PROCEDURES; HEALTH PLANNING GUIDELINES; HUMANS; MODELS, THEORETICAL; PRACTICE PATTERNS, PHYSICIANS'; TUBERCULOSIS, PULMONARY; UNCERTAINTY;

EID: 84908428702     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0110558     Document Type: Article

References (45)

1. Boehme CC, Saacks S, O'Brien RJ (2013) The changing landscape of diagnostic services for tuberculosis. Semin Respir Crit Care Med 34: 17-31.
2. McNerney R, Maeurer M, Abubakar I., Marais B, McHugh TD, et al. (2012) Tuberculosis diagnostics and biomarkers: needs, challenges, recent advances, and opportunities. J Infect Dis 205 Suppl 2: S147-158.
3. Pai M, Minion J, Steingart K., Ramsay A (2010) New and improved tuberculosis diagnostics: evidence, policy, practice, and impact. Curr Opin Pulm Med 16: 271-284.
4. Pai M, O'Brien R (2008) New diagnostics for latent and active tuberculosis: state of the art and future prospects. Semin Respir Crit Care Med 29: 560-568.
5. Dowdy DW, Cattamanchi A, Steingart K.R., Pai M (2011) Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis. PLoS Med 8: e1001063.
6. Bacaer N, Ouifki R, Pretorius C., Wood R, Williams B (2008) Modeling the joint epidemics of TB and HIV in a South African township. J Math Biol 57: 557-593.
7. Garnett GP, Cousens S, Hallett T.B., Steketee R., Walker N (2011) Mathematical models in the evaluation of health programmes. Lancet 378: 515-525.
8. Drummond M, Sculpher M, Torrance G., O'Bruen B, Stoddart G (2005) Methods for the economic evaluation of health care programmes. Oxford: Oxford University Press.
9. Uys PW, Warren RM, van Helden PD (2007) A threshold value for the time delay to TB diagnosis. PLoS One 2: e757.
10. Dye C (2012) The potential impact of new diagnostic tests on tuberculosis epidemics. Indian J Med Res 135: 737-744.
11. Millen SJ, Uys PW, Hargrove J, van Helden PD, Williams BG (2008) The effect of diagnostic delays on the drop-out rate and the total delay to diagnosis of tuberculosis. PLoS One 3: e1933.
12. Legrand J, Sanchez A, Le Pont F, Camacho L, Larouze B (2008) Modeling the impact of tuberculosis control strategies in highly endemic overcrowded prisons. PLoS One 3: e2100.
13. Basu S, Friedland GH, Medlock J, Andrews J.R., Shah NS, et al. (2009) Averting epidemics of extensively drug-resistant tuberculosis. Proc Natl Acad Sci U S A 106: 7672-7677.
14. Uys PW, Warren R, van Helden PD, Murray M, Victor TC (2009) Potential of rapid diagnosis for controlling drug-susceptible and drug-resistant tuberculosis in communities where Mycobacterium tuberculosis infections are highly prevalent. J Clin Microbiol 47: 1484-1490.
15. Dowdy DW, Basu S, Andrews JR (2013) Is passive diagnosis enough?: the impact of subclinical disease on diagnostic strategies for tuberculosis. Am J Respir Crit Care Med 187: 543-551.
16. Langley I, Doulla B, Lin H.H., Millington K., Squire B (2012) Modelling the impacts of new diagnostic tools for tuberculosis in developing countries to enhance policy decisions. Health Care Manag Sci 15: 239-253.
17. Lin HH, Dowdy D, Dye C., Murray M, Cohen T (2012) The impact of new tuberculosis diagnostics on transmission: why context matters. Bull World Health Organ 90: 739-747A.
18. Lin HH, Langley I, Mwenda R., Doulla B, Egwaga S, et al. (2011) A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Int J Tuberc Lung Dis 15: 996-1004.
19. Menzies NA, Cohen T, Lin H.H., Murray M., Salomon JA (2012) Population health impact and cost-effectiveness of tuberculosis diagnosis with Xpert MTB/RIF: a dynamic simulation and economic evaluation. PLoS Med 9: e1001347.
20. Winetsky DE, Negoescu DM, DeMarchis E.H., Almukhamedova O., Door-onbekova A, et al. (2012) Screening and rapid molecular diagnosis of tuberculosis in prisons in Russia and Eastern Europe: a cost-effectiveness analysis. PLoS Med 9: e1001348.
21. Abimbola TO, Marston BJ, Date A.A., Blandford JM, Sangrujee N, et al. (2012) Cost-Effectiveness of Tuberculosis Diagnostic Strategies to Reduce Early Mortality Among Persons With Advanced HIV Infection Initiating Antiretro-viral Therapy. JAIDS Journal of Acquired Immune Deficiency Syndromes 60: e1-e7 10.1097/QAI.1090b1013e318246538f.
22. Acuna-Villaorduna C, Vassall A, Henostroza G., Seas C, Guerra H, et al. (2008) Cost-effectiveness analysis of introduction of rapid, alternative methods to identify multidrug-resistant tuberculosis in middle-income countries. Clin Infect Dis 47: 487-495.
23. Albert H (2004) Economic analysis of the diagnosis of smear-negative pulmonary tuberculosis in South Africa: incorporation of a new rapid test, FASTPlaqueTB, into the diagnostic algorithm. Int J Tuberc Lung Dis 8: 240-247.
24. Andrews JR, Lawn SD, Rusu C, Wood R., Noubary F, et al. (2012) The cost-effectiveness of routine tuberculosis screening with Xpert MTB/RIF prior to initiation of antiretroviral therapy: a model-based analysis. AIDS 26: 987-995 910.1097/QAD.1090b1013e3283522d3283547.
25. Bonnet M, Tajahmady A, Hepple P., Ramsay A, Githui W, et al. (2010) Added value of bleach sedimentation microscopy for diagnosis of tuberculosis: a cost-effectiveness study. Int J Tuberc Lung Dis 14: 571-577.
26. Dowdy DW, Lourenco MC, Cavalcante S.C., Saraceni V., King B, et al. (2008) Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One 3: e4057.
27. Dowdy DW, Maters A, Parrish N., Beyrer C, Dorman SE (2003) Cost-effectiveness analysis of the gen-probe amplified mycobacterium tuberculosis direct test as used routinely on smear-positive respiratory specimens. Journal of clinical microbiology 41: 948-953.
28. Dowdy DW, Steingart KR, Pai M (2011) Serological testing versus other strategies for diagnosis of active tuberculosis in India: a cost-effectiveness analysis. PLoS Med 8: e1001074.
29. Guerra RL, Hooper NM, Baker J.F., Alborz R., Armstrong DT, et al. (2008) Cost-effectiveness of different strategies for amplified Mycobacterium tuberculosis direct testing for cases of pulmonary tuberculosis. J Clin Microbiol 46: 3811-3812.
30. Hughes R, Wonderling D, Li B., Higgins B (2012) The cost effectiveness of Nucleic Acid Amplification Techniques for the diagnosis of tuberculosis. Respiratory medicine 106: 300-307.
31. Lim TK, Cherian J, Poh K.L., Leong TY (2000) The rapid diagnosis of smear-negative pulmonary tuberculosis: a cost-effectiveness analysis. Respirology 5: 403-409.
32. Meyer-Rath G, Schnippel K, Long L., Macleod W, Sanne I, et al. (2012) The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa. PLoS One 7: e36966.
33. Rajalahti I, Ruokonen EL, Kotomaki T, Sintonen H., Nieminen MM (2004) Economic evaluation of the use of PCR assay in diagnosing pulmonary TB in a low-incidence area. Eur Respir J 23: 446-451.
34. Schnippel K, Meyer-Rath G, Long L., Stevens WS, Sanne I, et al. (2013) Diagnosing Xpert MTB/RIF negative TB: impact and cost of alternative algorithms for South Africa. S Afr Med J 103: 101-106.
35. Sun D, Dorman S, Shah M., Manabe YC, Moodley VM, et al. (2013) Cost utility of lateral-flow urine lipoarabinomannan for tuberculosis diagnosis in HIV-infected African adults. Int J Tuberc Lung Dis 17: 552-558.
36. Vassall A, van Kampen S, Sohn H, Michael J.S., John KR, et al. (2011) Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 8: e1001120.
37. Dowdy DW, O'Brien MA, Bishai D (2008) Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Int J Tuberc Lung Dis 12: 1021-1029.
38. Jones TF, Schaffner W (2001) Miniature chest radiograph screening for tuberculosis in jails: a cost-effectiveness analysis. Am J Respir Crit Care Med 164: 77-81.
39. Maheswaran H, Barton P (2012) Intensive case finding and isoniazid preventative therapy in HIV infected individuals in Africa: economic model and value of information analysis. PLoS One 7: e30457.
40. Resch SC, Salomon JA, Murray M, Weinstein MC (2006) Cost-effectiveness of treating multidrug-resistant tuberculosis. PLoS Med 3: e241.
41. Samandari T, Bishai D, Luteijn M., Mosimaneotsile B, Motsamai O, et al. (2011) Costs and consequences of additional chest x-ray in a tuberculosis prevention program in Botswana. Am J Respir Crit Care Med 183: 1103-1111.
42. Abu-Raddad LJ, Sabatelli L, Achterberg J.T., Sugimoto JD, Longini IM Jr, et al. (2009) Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. Proc Natl Acad Sci U S A 106: 13980-13985.
43. Dowdy DW, Chaisson RE, Maartens G, Corbett E.L., Dorman SE (2008) Impact of enhanced tuberculosis diagnosis in South Africa: a mathematical model of expanded culture and drug susceptibility testing. Proc Natl Acad Sci U S A 105: 11293-11298.
44. Dowdy DW, Chaisson RE, Moulton L.H., Dorman SE (2006) The potential impact of enhanced diagnostic techniques for tuberculosis driven by HIV: a mathematical model. AIDS 20: 751-762.
45. Barter DM, Agboola SO, Murray M.B., Barnighausen T (2012) Tuberculosis and poverty: the contribution of patient costs in sub-Saharan Africa-a systematic review. BMC Public Health 12: 980.